Personalis Inc Share Price Today: Live Updates & Key Insights

Personalis Inc share price today is $7.45, up 0.97%. The stock opened at $7.21 against the previous close of $7.19, with an intraday high of $7.31 and low of $7.04.

Personalis Inc Share Price Chart

Personalis Inc

us-stock
To Invest in {{usstockname}}
us-stock

Personalis Inc Share Price Performance

$7.45 0.0097(0.97%) PSNL at 23 Mar 2026 02:52 PM Diagnostics & Research
Lowest Today 7.04
Highest Today 7.31
Today’s Open 7.21
Prev. Close 7.19
52 Week High 11.50
52 Week Low 2.83
Day’s Range: Low 7.04 High 7.31
52-Week Range: Low 2.83 High 11.50
1 day return -
1 Week return +7.53
1 month return -12.18
3 month return -16.6
6 month return +18.37
1 year return +88.6
3 year return +169.62
5 year return -71.69
10 year return -

Personalis Inc Institutional Holdings

Merck & Co Inc 13.42

ARK Genomic Revolution ETF 7.87

Lightspeed Management Co LLC 7.80

ARK Investment Management LLC 7.53

ARK Genomic Revolution 7.24

BlackRock Inc 5.39

T. Rowe Price US Small-Cap Core Equity 3.40

Vanguard Group Inc 3.11

Aberdeen Group PLC 3.11

T. Rowe Price Small-Cap Stock 2.80

AIGH Capital Management, LLC 2.77

T. Rowe Price Investment Management,Inc. 2.76

CT (Lux) American Smaller Com 9U USD 2.25

Columbia Small Cap Growth 2.04

abrdn Healthcare Investors 1.81

Columbia Small Cap Growth Inst 1.77

Kennedy Capital Management Inc 1.64

T. Rowe Price Instl Small-Cap Stock 1.64

Blue Water Life Science Advisors, LLC 1.60

Vanguard Total Stock Mkt Idx Inv 1.59

T. Rowe Price U.S. SC Core Eq Tr-D 1.58

T. Rowe Price New Horizons 1.51

abrdn Life Sciences Investors 1.29

Geode Capital Management, LLC 1.24

CT American Smaller Coms(US) InstAccGBP 1.23

iShares Russell 2000 ETF 1.18

T. Rowe Price Small-Cap Value 1.09

T. Rowe Price US Smlr Coms Eq A 0.98

Dimensional Fund Advisors, Inc. 0.94

State Street Corp 0.89

US Small-Cap Growth II Equity Comp 0.86

Kennedy Small Cap Select 0.73

AZ Fd 1 - AZ Eq - Amer Opps A-EUR Acc 0.65

Next Century Growth Investors LLC 0.60

Sumitomo Mitsui Trust Group Inc 0.56

The Goldman Sachs Group Inc 0.55

Howland Capital Management Inc 0.52

Amova Asset Management Americas, Inc 0.50

State Treasurer State Of Michigan 0.47

Northern Trust Corp 0.38

Personalis Inc Market Status

Strong Buy: 4

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

Personalis Inc Fundamentals

Market Cap 759.63 M

PB Ratio 2.8803

PE Ratio 0.0

Enterprise Value 552.30 M

Total Assets 334.16 M

Volume 1917781

Personalis Inc Company Financials

Annual Revenue FY23:70528000 70.5M, FY22:65047000 65.0M, FY21:85494000 85.5M, FY20:78648000 78.6M, FY19:65207000 65.2M

Annual Profit FY23:15315000 15.3M, FY22:13350000 13.4M, FY21:31657000 31.7M, FY20:20114000 20.1M, FY19:22080000 22.1M

Annual Net worth FY23:-112780000 -112.8M, FY22:-113315000 -113.3M, FY21:-65226000 -65.2M, FY20:-41280000 -41.3M, FY19:-25084000 -25.1M

Quarterly Revenue Q3/2025:14495000 14.5M, Q2/2025:17203000 17.2M, Q1/2025:20605000 20.6M, Q3/2024:25709000 25.7M, Q2/2024:22580000 22.6M

Quarterly Profit Q3/2025:1914000 1.9M, Q2/2025:4756000 4.8M, Q1/2025:7207000 7.2M, Q3/2024:8745000 8.7M, Q2/2024:8037000 8.0M

Quarterly Net worth Q3/2025:-21652000 -21.7M, Q2/2025:-20056000 -20.1M, Q1/2025:-15750000 -15.8M, Q3/2024:-39089000 -39.1M, Q2/2024:-12802000 -12.8M

About Personalis Inc & investment objective

Company Information Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for the detection of MRD; and NeXT Dx, a tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. In addition, the company performs whole exome sequencing of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing on human samples for research projects, such as population sequencing initiatives. Its services are used by pharmaceutical companies for translational research, biomarker discovery, the development of personalized cancer therapies, and for clinical trials, as well as tests are used by physicians to detect residual or recurrent cancer in patients, monitor cancer response to therapy, and uncover insights for therapy selection. The company's customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and cancer patients. The company has strategic collaboration with Tempus AI, Inc. to bring testing to colorectal cancer patients. Personalis, Inc. was incorporated in 2011 and is headquartered in Fremont, California.

Organisation Diagnostics & Research

Employees 259

Industry Diagnostics & Research

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Personalis Inc FAQs

What is the share price of Personalis Inc today?

The current share price of Personalis Inc is $7.45.

Can I buy Personalis Inc shares in India?

Yes, Indian investors can buy Personalis Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Personalis Inc shares in India?

You can easily invest in Personalis Inc shares from India by:

Can I buy fractional shares of Personalis Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Personalis Inc?

Personalis Inc has a market cap of $759.63 M.

In which sector does Personalis Inc belong?

Personalis Inc operates in the Diagnostics & Research sector.

What documents are required to invest in Personalis Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Personalis Inc?

The PE ratio of Personalis Inc is N/A and the PB ratio is 2.88.